Management of gastric fundal varices without gastro-renal shunt in 15 patients

Table 1 Clinical characteristics of patients and profile of varices in GRS (+) and GRS (-) groups n (%)

	GRS (+)	GRS (-)	P
	(n = 79)	(n = 15)	value
Age: yr (range)	61.9 ± 10 (42-80)	61.5 ± 10 (44-76)	NS
Gender (Male:Female)	1:0.58	1:0.5	NS
Child-Pugh classification
A	47 (59.5)	6 (40)	NS
B	28 (35.4)	8 (53.3)	NS
C	4 (5.1)	1 (6.7)	NS
Endoscopic featres of GV
Form
F2	27 (34.1)	5 (33.3)	NS
F3	52 (65.8)	10 (66.7)	NS
Location
Lgf	12 (15.2)	4 (26.7)	NS
Lgcf	67 (84.8)	11 (73.3)	NS
Presence of red color spots	12 (15.2)	2 (13.3)	NS
History of GV bleeding	20 (25.3)	3 (20)	NS
Finding of CD-EUS
Blood vessel diameter (mm)	9.5 ± 3.4	6.7 ± 2.8a	0.009
Blood flow velocity (cm/s)	16.5 ± 4.3	14.5 ± 3.5	NS
Blood flow volume (cm3/s)	50.8 ± 45.0	26.1 ± 25.7a	0.043

NS: Not significant. GV: Gastric fundal varices; GRS: Gastro-renal shunt; CD-EUS: Color doppler endoscopic ultrasonography. Values for age and findings of CD- EUS are the median.

^aP < 0.05 vs GRS (+) group.

Table 2 Gastric fundal varices without gastro-renal shunt

Age	Sex	Form	Diameter (mm)	Verocity (cm/s)	Supplying vein	Drainage vein	Treatment
75	M	LgcfF2	6.8	9.3	Rgv, Sgv	Spv	CA
45	M	LgcF2	8.8	15.0	Lgv, Rgv	Spv	CA
69	F	LgcfF3	12.0	20.1	Lgv	Pe	CA
52	M	LgcfF2	6.1	14.3	Lgv, Sgv	Spv	CA
67	M	LgfF3	4.5	15.0	Lgv, Rgv	Spv, Pcv	PTO
66	M	LgcfF3	4.7	18.5	Lgv, Rgv, Sgv	Pcv	PTO
64	M	LgcF3	4.8	18.1	Rgv	Spv	PTO
65	M	LgcfF3	7.2	10.5	Rgv	Spv	PTO
76	F	LgcF2	3.8	12.0	Lgv	Spv, Pev	PTO
44	F	LgcfF3	8.0	13.0	Rgv, Lgv	Spv, Pcv	BRTO
66	F	LgfF3	11.0	17.7	Rgv	Spv	BRTO
54	M	LgfF3	10.0	17.7	Lgv	Spv	BRTO
52	M	LgfF3	6.0	15.6	Lgv, Rgv, Sgv	Spv, Pcv	BRTO
64	M	LgcfF3	4.4	12.4	Sgv	Spv	BRTO
63	M	LgcF2	2.0	8.9	Lgv	Spv	BRTO

CA: Endoscopic injection sclerotherapy using α-cyanoacrylate glue; Rgv: Retro gastric vein; Sgv: Short gastric vein; Lgv: Left gastric vein; Spv: Subphrenic vein; Pev: Para esophageal vein; Pcv: Peri-cardial vein; BRTO: Balloon occluded retrograde transvenous obliteration; PTO: Percutaneous transhepatic obliteration.

Table 3 Treatment methods and recurrence rate of varices in GRS (-) group n (%)

GRS (-)	n= 15	P value
Treatment
BRTO	6 (40)	NS
PTO	5 (33)	NS
CA	4 (27)	NS
Early recurrence rate within 6 mo
BRTO	1 (16.7)
PTO	2 (40)
CA	2 (50)

BRTO: Balloon-occluded retrograde transvenous obliteration; PTO: Percutaneous transhepatic obliteration; CA: Endoscopic injection sclerotherapy using α-cyanoacrylate glue; GRS: Gastro-renal shunt.